Despite the great advancements in the treatment of AML, these criteria have remained largely unchanged over the last decades. In paediatric patients, these criteria were adopted in a modified form as ...

Flow cytometry effectively detects CTCs in melanoma patients, offering a rapid, cost-effective alternative to molecular biology. CTCs are present across all melanoma stages, with a significant ...

Designed to set a new standard in spectral flow cytometry, the Cytek Aurora Evo flow cytometer maintains the reproducibility researchers rely on, now with added high-throughput performance and ...

This report describes the development and validation of a cellular, immunofluorescence-based flow cytometry assay that allows detection of intranuclear hTERT while maintaining identifiable cell ...

As the incidence of cancer rises around the world, the demand for faster, more precise diagnoses is also on the rise. This demand will only intensify over time, as the worldwide incidence of ...

First launched in 2017 to address the limitations of existing flow cytometry technologies ... section entitled "Risk Factors” set forth in Cytek's Quarterly Report on Form 10-Q filed on May 8, 2025 ...

First launched in 2017 to address the limitations of existing flow cytometry technologies ... set forth in Cytek’s Quarterly Report on Form 10-Q filed on May 8, 2025 with the SEC, and other ...

In addition, the development of more effective and less toxic induction regimens with a backbone of venetoclax and hypomethylating agents is a real advance in therapy for older or less fit patients ...

Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion. Chart shareholders will receive 3.165 shares of ...